CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Common stock	Additional Paid in Capital	Accumulated Deficit	Total
Beginning Balance at Dec. 31, 2020	$ 24	$ 345,529	$ (138,857)	$ 206,696
Beginning Balance (in shares) at Dec. 31, 2020	24,417
Stock-based compensation		5,565		5,565
Exercise of stock options	$ 1	851		852
Exercise of stock options (in shares)	214
Net loss			(26,376)	(26,376)
Ending Balance at Mar. 31, 2021	$ 25	351,945	(165,233)	186,737
Ending Balance (in shares) at Mar. 31, 2021	24,631
Beginning Balance at Dec. 31, 2020	$ 24	345,529	(138,857)	206,696
Beginning Balance (in shares) at Dec. 31, 2020	24,417
Net loss				(80,806)
Ending Balance at Sep. 30, 2021	$ 28	465,191	(219,663)	245,556
Ending Balance (in shares) at Sep. 30, 2021	27,980
Beginning Balance at Mar. 31, 2021	$ 25	351,945	(165,233)	186,737
Beginning Balance (in shares) at Mar. 31, 2021	24,631
Issuance of common stock, net of issuance costs	$ 3	101,024		101,027
Issuance of common stock, net of issuance costs (in shares)	3,279
Stock-based compensation		6,769		6,769
Exercise of stock options		497		497
Exercise of stock options (in shares)	59
Net loss			(27,619)	(27,619)
Ending Balance at Jun. 30, 2021	$ 28	460,235	(192,852)	267,411
Ending Balance (in shares) at Jun. 30, 2021	27,969
Stock issuance costs		(34)		(34)
Stock-based compensation		4,885		4,885
Exercise of stock options		105		105
Exercise of stock options (in shares)	11
Net loss			(26,811)	(26,811)
Ending Balance at Sep. 30, 2021	$ 28	465,191	(219,663)	245,556
Ending Balance (in shares) at Sep. 30, 2021	27,980
Beginning Balance at Dec. 31, 2021	$ 28	467,427	(245,788)	$ 221,667
Beginning Balance (in shares) at Dec. 31, 2021	27,980			27,980
Stock-based compensation		3,825		$ 3,825
Net loss			(31,472)	(31,472)
Ending Balance at Mar. 31, 2022	$ 28	471,252	(277,260)	194,020
Ending Balance (in shares) at Mar. 31, 2022	27,980
Beginning Balance at Dec. 31, 2021	$ 28	467,427	(245,788)	$ 221,667
Beginning Balance (in shares) at Dec. 31, 2021	27,980			27,980
Issuance of stock purchase warrants				$ 3,245
Net loss				(110,949)
Ending Balance at Sep. 30, 2022	$ 28	483,695	(356,737)	$ 126,986
Ending Balance (in shares) at Sep. 30, 2022	28,023			28,023
Beginning Balance at Mar. 31, 2022	$ 28	471,252	(277,260)	$ 194,020
Beginning Balance (in shares) at Mar. 31, 2022	27,980
Stock-based compensation		4,482		4,482
Issuance of stock purchase warrants		3,245		3,245
Exercise of stock options		185		185
Exercise of stock options (in shares)	38
Net loss			(37,672)	(37,672)
Ending Balance at Jun. 30, 2022	$ 28	479,164	(314,932)	164,260
Ending Balance (in shares) at Jun. 30, 2022	28,018
Stock-based compensation		4,483		4,483
Exercise of stock options		48		48
Exercise of stock options (in shares)	5
Net loss			(41,805)	(41,805)
Ending Balance at Sep. 30, 2022	$ 28	$ 483,695	$ (356,737)	$ 126,986
Ending Balance (in shares) at Sep. 30, 2022	28,023			28,023